[go: up one dir, main page]

RO63064A - Procede d'obtenir un inhibiteur pour glycosidhydrolases - Google Patents

Procede d'obtenir un inhibiteur pour glycosidhydrolases

Info

Publication number
RO63064A
RO63064A RO7100081898A RO8189871A RO63064A RO 63064 A RO63064 A RO 63064A RO 7100081898 A RO7100081898 A RO 7100081898A RO 8189871 A RO8189871 A RO 8189871A RO 63064 A RO63064 A RO 63064A
Authority
RO
Romania
Prior art keywords
glycosidhydrolases
inhibitor
obtaining
Prior art date
Application number
RO7100081898A
Other languages
English (en)
Romanian (ro)
Inventor
Werner Frommer
Walter Puls
Dietmar Schaefer
Delf Schmidt
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of RO63064A publication Critical patent/RO63064A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces
    • Y10S435/896Streptomyces fradiae
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/907Streptosporangium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
RO7100081898A 1970-12-28 1971-12-24 Procede d'obtenir un inhibiteur pour glycosidhydrolases RO63064A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2064092A DE2064092C2 (de) 1970-12-28 1970-12-28 Inhibitoren für Glykosidhydrolasen aus Actinomyceten

Publications (1)

Publication Number Publication Date
RO63064A true RO63064A (fr) 1978-06-15

Family

ID=5792372

Family Applications (3)

Application Number Title Priority Date Filing Date
RO9182*[A RO61400A (fr) 1970-12-28 1971-12-24
RO7100081898A RO63064A (fr) 1970-12-28 1971-12-24 Procede d'obtenir un inhibiteur pour glycosidhydrolases
RO7181890A RO63065A (fr) 1970-12-28 1971-12-24 Procede d'obtention d'un inhibiteur de glycosidehydrolase

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RO9182*[A RO61400A (fr) 1970-12-28 1971-12-24

Family Applications After (1)

Application Number Title Priority Date Filing Date
RO7181890A RO63065A (fr) 1970-12-28 1971-12-24 Procede d'obtention d'un inhibiteur de glycosidehydrolase

Country Status (28)

Country Link
US (1) US3876766A (fr)
JP (3) JPS5734996B1 (fr)
KR (1) KR780000248B1 (fr)
AR (1) AR193370A1 (fr)
AT (1) AT330122B (fr)
AU (1) AU461521B2 (fr)
BE (1) BE777387A (fr)
BG (3) BG25654A3 (fr)
CA (1) CA979833A (fr)
CH (1) CH594051A5 (fr)
CS (1) CS167961B2 (fr)
DD (1) DD99395A5 (fr)
DE (1) DE2064092C2 (fr)
DK (1) DK139533C (fr)
ES (1) ES398358A1 (fr)
FI (1) FI49774C (fr)
FR (1) FR2120073B1 (fr)
GB (1) GB1374751A (fr)
IE (1) IE35920B1 (fr)
IL (1) IL38441A (fr)
LU (1) LU64319A1 (fr)
NL (1) NL175199C (fr)
NO (1) NO135873C (fr)
PL (1) PL82900B1 (fr)
RO (3) RO61400A (fr)
SE (1) SE398357B (fr)
SU (1) SU454750A3 (fr)
ZA (1) ZA718677B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2209833C3 (de) * 1972-03-01 1978-06-01 Bayer Ag, 5090 Leverkusen Herstellung eines Amylaseinhibitors
DE2209832C3 (de) * 1972-03-01 1979-03-29 Bayer Ag, 5090 Leverkusen Herstellung von Saccharaseinhibitoren
DE2209834C3 (de) * 1972-03-01 1978-04-20 Bayer Ag, 5090 Leverkusen Herstellung von Saccharase-Inhibitoren
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
US4010258A (en) * 1974-03-15 1977-03-01 Ajinomoto Co., Inc. Microbial amylase inhibitor and preparation thereof with the use of streptomyces diasticus var. amylostaticus
US4065557A (en) * 1974-03-21 1977-12-27 Bayer Aktiengesellschaft Amino sugars and their use in improving the meat:fat ratio in animals
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
FR2338707A1 (fr) * 1976-01-22 1977-08-19 Rhone Poulenc Ind Nouvel inhibiteur de glyco-hydrolases et sa preparation par culture d'un streptomyces
DE2658563A1 (de) * 1976-12-23 1978-06-29 Bayer Ag Inhibitoren fuer glykosid-hydrolasen aus bacillen
DE2701890C2 (de) * 1977-01-19 1983-08-04 Hoechst Ag, 6230 Frankfurt Peptielischer Glycosidhydrolase-Inhibitor aus einem Streptomyceten und seine Verwendung
DE2719912C3 (de) * 1977-05-04 1979-12-06 Bayer Ag, 5090 Leverkusen Verfahren zur Isolierung von 0- |4,6-Dideoxy-4- [JJl S-O,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a -D-glucopyranosyl} -(I Pfeil nach rechts 4)-0- a D-glucopyranosyl-(l Pfeil nach rechts 4)-D-glucopyranose aus Kulturbrühen
GB2016497A (en) * 1978-02-10 1979-09-26 Taisho Pharmaceutical Co Ltd Microbiological production of amylase inhibitor
CA1121290A (fr) * 1978-02-14 1982-04-06 Yasuji Suhara Derives amines d'un sucre
JPS62160696A (ja) * 1986-01-07 1987-07-16 シャープ株式会社 電子式自動点滅器
EP0257418B1 (fr) * 1986-08-13 1993-05-19 Hoechst Aktiengesellschaft Oxirane-pseudo-oligosaccharides, procédé pour leur synthèse, leur utilisation et préparations pharmaceutiques
US5464828A (en) * 1988-03-02 1995-11-07 Chugai Pharmaceutical Co., Ltd. Aqueous suspension of sucralfate
DE19507214A1 (de) * 1995-03-02 1996-10-31 Bayer Ag Acarbose-Biosynthesegene aus Actinoplanes sp., Verfahren zu ihrer Isolierung sowie ihre Verwendung
EP0796915A3 (fr) * 1996-03-22 1999-04-14 Bayer Ag Procédé de préparation et utilisation d'acarviosyl-transferase dans la conversion d'homologues d'acarbose et dans la préparation d'homologues d'acarbose
DE19637591A1 (de) * 1996-09-13 1998-03-19 Bayer Ag Osmokontrolliertes Fermentationsverfahren zur Herstellung von Acarbose
US6649755B1 (en) 1999-10-28 2003-11-18 Chong Kun Dang Pharmaceutical Corp. Process for preparing acarbose with high purity
HRP20010792A2 (en) 2001-10-26 2003-04-30 Pliva D D Acarbose purification process
US9217154B2 (en) 2011-12-08 2015-12-22 Bayer Intellectual Property Gmbh Actinomycete integrative and conjugative element from Actinoplanes sp. SE50/110 as plasmid for genetic transformation of related Actinobacteria
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US20230227879A1 (en) 2019-10-16 2023-07-20 Bayer Aktiengesellschaft Methods for the improved formation of acarbose
US11802838B2 (en) 2020-03-23 2023-10-31 Bay State Milling Company Rapid high amylose wheat seed purity test

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3127315A (en) * 1964-03-31 Hypocholesterolemic agent m-

Also Published As

Publication number Publication date
NO135873C (fr) 1977-06-15
PL82900B1 (fr) 1975-10-31
BG25654A3 (bg) 1978-11-10
DD99395A5 (fr) 1973-08-05
RO61400A (fr) 1977-01-15
IL38441A (en) 1974-10-22
AT330122B (de) 1976-06-10
BE777387A (fr) 1972-06-28
IE35920L (en) 1972-06-28
JPS57150396A (en) 1982-09-17
AU461521B2 (en) 1975-05-29
FI49774C (fi) 1975-10-10
JPS5734996B1 (fr) 1982-07-26
CA979833A (en) 1975-12-16
GB1374751A (en) 1974-11-20
JPS6216638B2 (fr) 1987-04-14
CH594051A5 (fr) 1977-12-30
BG26002A4 (bg) 1979-01-12
NL175199B (nl) 1984-05-01
AU3721471A (en) 1973-09-27
FI49774B (fr) 1975-06-30
US3876766A (en) 1975-04-08
DK139533B (da) 1979-03-05
KR780000248B1 (en) 1978-07-06
DK139533C (da) 1979-08-20
IE35920B1 (en) 1976-06-23
BG26003A4 (bg) 1979-01-12
JPS57150395A (en) 1982-09-17
LU64319A1 (fr) 1972-06-13
SE398357B (sv) 1977-12-19
IL38441A0 (en) 1972-02-29
AR193370A1 (es) 1973-04-23
NL175199C (nl) 1984-10-01
CS167961B2 (fr) 1976-05-28
DE2064092C2 (de) 1983-06-01
ZA718677B (en) 1972-09-27
ES398358A1 (es) 1974-09-01
JPS6234396B2 (fr) 1987-07-27
RO63065A (fr) 1979-02-15
FR2120073A1 (fr) 1972-08-11
SU454750A3 (ru) 1974-12-25
ATA1111571A (de) 1975-09-15
NL7117893A (fr) 1972-06-30
FR2120073B1 (fr) 1975-12-26
DE2064092A1 (de) 1972-07-20
NO135873B (fr) 1977-03-07

Similar Documents

Publication Publication Date Title
RO63064A (fr) Procede d'obtenir un inhibiteur pour glycosidhydrolases
BG20360A3 (bg) Метод за получаване на нови субституирани n-алил-2-ариламино -имидазолини -(2)
BG17775A3 (bg) Метод за получаване на заместени n-амино-алкил- ариламино-имидазолини-/2/
BG19148A3 (bg) Метод за получаване на 5,6,7,8-заместени -хромон-2-карбонови киселини
BE763148A (fr) Procede pour la production de methanol
BG25985A3 (bg) Метод за получаване на 13 бета-етил-17 d-етинил-гон- -4-еп-3-он-17 бета-ол
BG16748A3 (bg) Метод за получаване на нови субституирани n-циклоалкил- ариламино-имидазолини-(2)
BG20100A3 (bg) Метод за получаване на 1-фенокси-2-хидрокси-3- хидроалкил-аминопропани
BG19589A3 (bg) Метод за получаване на фениламиноалкани
BG20610A3 (bg) Метод за получаване на триазени
RO63472A (fr) Procede pour obtenir un inhibiteur d'amylase
RO63190A (fr) Procede pour obtenir un benzylthiocarbonate
BE760906A (fr) Composition et procede pour inhiber la corrosion
BG19373A3 (bg) Метод за получаване на тиокарбамиди
BE772461A (fr) Procede d'hydroformylation d'un alcene
BE777238A (fr) Dioxypiperidines substituees et procede pour les
SU426992A1 (fr)
BG19138A3 (bg) Метод за получаване на фенилкарбамиди
SU457695A1 (ru) Способ получени -аминопропионитрила
SU425946A1 (fr)
IT942106B (it) Apparecchio per la fabbricazione di ghiaccio
BG22819A3 (bg) Метод за получаване на 3--амино-пиразолони-(5)
SU539666A1 (ru) Способ непрерывной разливки металла
BG17963A3 (bg) Метод за получаване на нови карденалид- рамнозиди
BG18416A3 (bg) Метод за получаване на n-винилхинолони